Bain Capital, Hellman near Athenahealth buyout deal - WSJ
Reuters
Published Nov 19, 2021 06:24PM ET
(Reuters) - Private-equity firms Bain Capital and Hellman & Friedman LLC are close to a deal to acquire healthcare technology company Athenahealth Inc for about $17 billion including debt, the Wall Street Journal reported on Friday, citing people familiar with the matter.
The deal for Athenahealth, which provides cloud-based software to healthcare organizations, could be finalized in the coming days, according to the report.
In September, it was reported that private-equity firm Veritas Capital and hedge fund Elliott Investment were exploring options for Athenahealth including a sale or initial public offering which could be valued at up to $20 billion.
Elliott Investment and Veritas had partnered in 2018 for a $5.7 billion deal to take Athenahealth private, after which the company was merged with a healthcare unit that Vertias had acquired from General Electric (NYSE:GE).
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.